#Genomics Market demands

[alicetleibowitz]

Explore the dynamic landscape of the Genomics market, where cutting-edge technologies converge with healthcare innovation to unlock the mysteries of our genetic blueprint.

[versatile-blogger-1]

Global Spatial Genomics Transcriptomics Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Spatial Genomics Technologies

Market Overview: Spatial genomics transcriptomics combines the technologies of spatial transcriptomics and genomics to analyze gene expression within the context of tissue architecture. This innovative approach allows researchers to study the spatial organization of gene expression within individual cells, leading to a better understanding of various biological processes and disease mechanisms. The market for spatial genomics transcriptomics is driven by the increasing adoption of these technologies in various research applications, including cancer research, neurobiology, developmental biology, and immunology. The ability to analyze gene expression within the context of tissue architecture provides valuable insights into cell-to-cell interactions, cellular heterogeneity, and spatial relationships, making it a powerful tool for biomedical research. The global Spatial Genomics Transcriptomics Market Size is estimated to be valued at US$ 262.7 million in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Key Trends: One key trend driving the growth of the spatial genomics transcriptomics market is the increasing demand for single-cell analysis. Single-cell analysis allows researchers to study individual cells rather than bulk population samples, providing a deeper understanding of cellular heterogeneity and development. Spatial genomics transcriptomics takes single-cell analysis a step further by incorporating spatial information, enabling researchers to study gene expression within the context of tissue architecture. This integrated approach allows for a more comprehensive analysis of complex biological systems and has the potential to revolutionize our understanding of cellular processes and disease mechanisms. For example, 10x Genomics, one of the key players in the spatial genomics transcriptomics market, offers the Visium Spatial Gene Expression Solution, which enables researchers to analyze gene expression in intact tissue sections. This technology allows for the identification of cell types, mapping of gene expression, and analysis of the spatial relationships between cells. By combining single-cell analysis with spatial information, researchers can gain valuable insights into the role of gene expression in tissue development and disease progression. PEST Analysis: Political: The spatial genomics transcriptomics market is influenced by government regulations and policies regarding genomics research and healthcare. Government funding and support for research initiatives can drive market growth. Economic: The market is driven by increasing investment in genomics research and the growing demand for personalized medicine. The economic factors, such as GDP growth, healthcare expenditure, and disposable income, also impact the adoption of spatial genomics transcriptomics technologies. Social: The growing prevalence of chronic diseases and the need for better diagnostic and treatment options are driving the demand for spatial genomics transcriptomics technologies. The increasing awareness and acceptance of personalized medicine among patients and healthcare professionals are also contributing to market growth. In conclusion, the spatial genomics transcriptomics market is poised for significant growth due to the increasing adoption of these technologies in various research applications. The integration of spatial information with gene expression data provides valuable insights into cellular processes and disease mechanisms, driving the demand for spatial genomics transcriptomics technologies. With advancements in genomics research and technological innovation, this market is set to revolutionize our understanding of biology and contribute to the development of personalized medicine.

[nerdybeardcollective]

Investment Surge in GLP-1 Drugs Market: Trends and Future Prospects

Market Growth and Investment Trends

The GLP-1 drugs market has seen substantial investment from pharmaceutical companies and venture capitalists. This is driven by the increasing prevalence of type 2 diabetes and obesity, coupled with the efficacy of GLP-1 drugs in managing these conditions. Key trends include:

Rising Prevalence of Diabetes and Obesity: The global rise in lifestyle-related health issues is fueling demand for effective treatments.

Innovative Drug Development: Companies are investing heavily in R&D to develop next-generation GLP-1 drugs with improved efficacy and fewer side effects.

Strategic Collaborations and Partnerships: Collaborations between pharmaceutical giants and biotech firms are accelerating innovation and market entry of new drugs.

Recent Developments

Several notable developments have occurred in the GLP-1 drugs market:

New Drug Approvals: Regulatory bodies like the FDA and EMA have recently approved several new GLP-1 receptor agonists, expanding treatment options.

Clinical Trials and Research: Ongoing clinical trials are investigating the broader therapeutic potential of GLP-1 drugs, including their effects on cardiovascular health and non-alcoholic fatty liver disease (NAFLD).

Technological Advancements: Innovations in drug delivery systems, such as oral formulations and long-acting injectables, are enhancing patient compliance and convenience.

Browse Press Release

Future Opportunities

The future of the GLP-1 drugs market holds numerous opportunities for growth and innovation:

Expansion into New Therapeutic Areas: Research suggests potential applications of GLP-1 drugs in conditions beyond diabetes and obesity, such as neurodegenerative diseases and inflammation.

Personalized Medicine: Advances in genomics and biomarkers may enable personalized GLP-1 therapies tailored to individual patient profiles, improving outcomes.

Emerging Markets: Increasing healthcare access and rising diabetes prevalence in emerging markets present significant growth opportunities for GLP-1 drugs.

Conclusion

The GLP-1 drugs market is poised for remarkable growth, driven by robust investment, innovative developments, and expanding therapeutic applications. As research progresses and new technologies emerge, GLP-1 receptor agonists will play a crucial role in addressing the global burden of diabetes, obesity, and potentially other diseases, offering improved health outcomes for millions.

About iDataAcumen

iDataAcumen is a global business intelligence and management consulting firm providing data driven solutions to a wide array of business challenges. Our clients are present across major geographies globally and belong to industries ranging mainly from healthcare, pharmaceuticals, life science, biotechnology, medical devices, food industry, chemicals, among others. We have catered to more than 500 clients across these industries.

We aspire to help our clients build a sustainable business by providing them robust business insights that are derived from sound data driven analysis. In today’s ever changing business environment, its become important to look objectively at your own business just as it is important to look at the competition. Technological advancement including but not limited to big data, artificial intelligence, and machine learning are helping industries worldwide to make informed business decisions. Our research process also makes use of some of these advanced tools to uncover valuable insights from vast amount of data to arrive at logical conclusions.

[rajdhami01-blog]

Emerging Trends in Pharmaceutical Education 

Pharmaceutical education is experiencing a transformative shift in response to rapid advancements in the field of healthcare and the evolving needs of the global population. As we step into a future characterised by personalised medicine, precision therapies, and breakthrough technologies, the training and education of future pharmacists and pharmaceutical professionals are adapting to keep pace. In this blog, we will bring forth the latest developments and emerging trends in pharmaceutical education. 

According to Statista Pharmaceutical Market Forecast, the pharmaceutical industry has witnessed a rapid metamorphosis, with revenue expected to show an annual growth rate (CAGR 2023-2028) of 5.80%, resulting in a market volume of US$1,478.00bn by 2028, reflecting the sector's exponential growth. This growth is propelled by various factors, including an aging population, the rise of chronic diseases, and the increasing demand for personalised treatments. In response, pharmaceutical education is adapting to equip aspiring pharmacists and professionals with the skills and knowledge needed to navigate this dynamic and ever-evolving industry. 

1. Integration of Technology and Digital Learning 

In recent years, the integration of technology into pharmaceutical education has become ubiquitous. Digital platforms, virtual labs, simulation software, and online courses are revolutionizing the way students learn and engage with the subject matter. Augmented Reality (AR) and Virtual Reality (VR) are being utilized to create immersive learning experiences, allowing students to visualize complex pharmaceutical concepts in a more interactive and dynamic manner. These technologies enhance understanding and retention, ultimately preparing students for the technologically advanced landscape of modern healthcare. 

2. Focus on Interdisciplinary Learning 

Pharmaceutical education is embracing an interdisciplinary approach, fostering collaboration between pharmacy students and professionals from other healthcare domains. Interdisciplinary learning encourages a holistic understanding of healthcare systems and enables students to work seamlessly in a team-based environment. Collaborations with medical practitioners, bioinformatics experts, data scientists, and engineers expose students to diverse perspectives and problem-solving strategies, preparing them to be well-rounded professionals in an interdisciplinary healthcare landscape. 

3. Personalised and Individualised Learning 

Recognizing the unique learning styles and paces of individual students, personalized learning is gaining traction in pharmaceutical education. Tailoring educational experiences to meet the specific needs and preferences of students allows for a more effective learning process. Adaptive learning technologies use data analytics to track student progress and adapt the content and pace of learning accordingly. This approach optimizes comprehension and retention, ensuring that each student achieves their educational goals. 

4. Integration of Pharmacogenomics and Genetics 

Advancements in pharmacogenomics and genetics are transforming pharmaceutical education by necessitating a deeper understanding of how genetic variations influence drug responses. Modern curricula are incorporating in-depth studies of genomics, pharmacogenomics, and genetic testing to equip future pharmacists with the knowledge and skills to provide personalized medication recommendations based on an individual's genetic makeup. This personalized approach improves patient outcomes and reduces adverse reactions. 

5. Emphasis on Soft Skills and Professionalism 

Pharmaceutical education is evolving to place greater emphasis on soft skills and professionalism. Effective communication, leadership, critical thinking, and empathy are essential qualities for pharmaceutical professionals. Educational programs now integrate courses and workshops that enhance these skills, preparing students not only to excel in their technical roles but also to effectively interact with patients, colleagues, and healthcare stakeholders. 

6. Experiential Learning and Practical Exposure 

Traditional classroom-based learning is being complemented with experiential learning and practical exposure in real-world healthcare settings. Internships, externships, and rotations in community pharmacies, hospitals, research laboratories, and pharmaceutical industries provide students with valuable hands-on experience. These opportunities bridge the gap between theory and practice, enabling students to apply their knowledge in real-life scenarios and develop the necessary skills and confidence for their future careers. 

7. Environmental and Global Health Perspectives 

As sustainability and global health become paramount concerns, pharmaceutical education is incorporating curricula that address the environmental impact of pharmaceuticals and global health challenges. Students are exposed to the concepts of eco-friendly pharmaceutical practices, responsible drug manufacturing, and the role of pharmacists in addressing global health issues. This broadens their understanding of the industry's impact on the planet and society, encouraging responsible and ethical practices. 

Pioneering Pharmaceutical Education in India 

Shoolini University stands at the forefront of innovative pharmaceutical education in India. Renowned for its commitment to academic excellence, state-of-the-art infrastructure, and emphasis on holistic development, Shoolini University has emerged as a top choice for students aspiring to excel in the pharmaceutical field. Let's delve into the details of the pharmaceutical education offerings and the esteemed Faculty of Pharmaceutical Sciences at Shoolini University. 

Here are some highlights of Shoolini University's exceptional pharmaceutical education: 

Faculty from prestigious institutions worldwide, including University of Innsbruck (Austria), University of Constance (Germany), Chang Won National University (South Korea), and NIPER. 

Pharma NIRF Rank 41 (All India), reflecting the university's academic prowess and standing in the pharmaceutical education landscape. 

The Faculty of Pharmaceutical Sciences boasts 104+ cutting-edge laboratories across the university, providing students with extensive practical exposure and fostering research and innovation. 

Students receive scholarships and fellowships at both undergraduate (UG) and postgraduate (PG) levels, encouraging academic excellence and reducing the financial burden on students. 

An application-oriented curriculum that prepares students for real-world challenges, ensuring they are industry-ready upon graduation. 

Programs Offered by Shoolini University

Program 1

B Pharmacy 

Duration : 4 years 

Eligibility : 10+2 (PCB/PCM) with minimum 60% marks 

Program 2

B Pharmacy LEET 

Duration : 3 years 

Eligibility : Diploma in Pharmacy with 60% marks from a Pharmacy Council of India approved institution 

Program 3

M Pharma Pharmacology 

Duration : 2 years 

Eligibility : B Pharmacy from an institution approved by the Pharmacy Council of India with minimum 55% marks 

Program 4

M Pharmacy Pharmaceutical Chemistry 

Duration : 2 years 

Eligibility : B Pharmacy from an institution approved by the Pharmacy Council of India with minimum 55% marks 

Program 5

M Pharmacy Pharmaceutics 

Duration : 2 years 

Eligibility : B Pharmacy from an institution approved by the Pharmacy Council of India with minimum 55% marks 

Program 6

PhD Pharma 

Duration : 3 years 

Eligibility : Four-year graduation degree by research or master's degree in related discipline with minimum 55% marks 

In conclusion, Shoolini University is leading the way in pharmaceutical education in India, aligning its programs with the evolving trends and demands of the healthcare industry. Through a focus on innovation, interdisciplinary learning, practical exposure, and a dedicated faculty, Shoolini University equips its students to contribute significantly to the advancement of pharmaceutical sciences and improve healthcare outcomes for individuals and communities. 

[cybersecurityict]

Exascale Computing Market Size, Share, Analysis, Forecast, and Growth Trends to 2032: The Race to One Quintillion Calculations Per Second

The Exascale Computing Market was valued at USD 3.47 billion in 2023 and is expected to reach USD 29.58 billion by 2032, growing at a CAGR of 26.96% from 2024-2032.

The Exascale Computing Market is undergoing a profound transformation, unlocking unprecedented levels of computational performance. With the ability to process a billion billion (quintillion) calculations per second, exascale systems are enabling breakthroughs in climate modeling, genomics, advanced materials, and national security. Governments and tech giants are investing aggressively, fueling a race for exascale dominance that’s reshaping industries and redefining innovation timelines.

Exascale Computing Market revolutionary computing paradigm is being rapidly adopted across sectors seeking to harness the immense data-crunching potential. From predictive simulations to AI-powered discovery, exascale capabilities are enabling new frontiers in science, defense, and enterprise. Its impact is now expanding beyond research labs into commercial ecosystems, paving the way for smarter infrastructure, precision medicine, and real-time global analytics.

Get Sample Copy of This Report: https://www.snsinsider.com/sample-request/6035 

Market Keyplayers:

Hewlett Packard Enterprise (HPE) [HPE Cray EX235a, HPE Slingshot-11]

International Business Machines Corporation (IBM) [IBM Power System AC922, IBM Power System S922LC]

Intel Corporation [Intel Xeon Max 9470, Intel Max 1550]

NVIDIA Corporation [NVIDIA GH200 Superchip, NVIDIA Hopper H100]

Cray Inc. [Cray EX235a, Cray EX254n]

Fujitsu Limited [Fujitsu A64FX, Tofu interconnect D]

Advanced Micro Devices, Inc. (AMD) [AMD EPYC 64C 2.0GHz, AMD Instinct MI250X]

Lenovo Group Limited [Lenovo ThinkSystem SD650 V3, Lenovo ThinkSystem SR670 V2]

Atos SE [BullSequana XH3000, BullSequana XH2000]

NEC Corporation [SX-Aurora TSUBASA, NEC Vector Engine]

Dell Technologies [Dell EMC PowerEdge XE8545, Dell EMC PowerSwitch Z9332F]

Microsoft [Microsoft Azure NDv5, Microsoft Azure HPC Cache]

Amazon Web Services (AWS) [AWS Graviton3, AWS Nitro System]

Sugon [Sugon TC8600, Sugon I620-G30]

Google [Google TPU v4, Google Cloud HPC VM]

Alibaba Cloud [Alibaba Cloud ECS Bare Metal Instance, Alibaba Cloud HPC Cluster]

Market Analysis The exascale computing landscape is characterized by high-stakes R&D, global governmental collaborations, and fierce private sector competition. With countries like the U.S., China, and members of the EU launching national initiatives, the market is shaped by a mix of geopolitical strategy and cutting-edge technology. Key players are focusing on developing energy-efficient architectures, innovative software stacks, and seamless integration with artificial intelligence and machine learning platforms. Hardware giants are partnering with universities, startups, and defense organizations to accelerate deployments and overcome system-level challenges such as cooling, parallelism, and power consumption.

Market Trends

Surge in demand for high-performance computing in AI and deep learning

Integration of exascale systems with cloud and edge computing ecosystems

Government funding and national strategic investments on the rise

Development of heterogeneous computing systems (CPUs, GPUs, accelerators)

Emergence of quantum-ready hybrid systems alongside exascale architecture

Adoption across healthcare, aerospace, energy, and climate research sectors

Market Scope

Supercomputing for Scientific Discovery: Empowering real-time modeling and simulations at unprecedented speeds

Defense and Intelligence Advancements: Enhancing cybersecurity, encryption, and strategic simulations

Precision Healthcare Applications: Supporting drug discovery, genomics, and predictive diagnostics

Sustainable Energy Innovations: Enabling complex energy grid management and fusion research

Smart Cities and Infrastructure: Driving intelligent urban planning, disaster management, and IoT integration

As global industries shift toward data-driven decision-making, the market scope of exascale computing is expanding dramatically. Its capacity to manage and interpret massive datasets in real-time is making it essential for competitive advantage in a rapidly digitalizing world.

Market Forecast The trajectory of the exascale computing market points toward rapid scalability and broader accessibility. With increasing collaborations between public and private sectors, we can expect a new wave of deployments that bridge research and industry. The market is moving from proof-of-concept to full-scale operationalization, setting the stage for widespread adoption across diversified verticals. Upcoming innovations in chip design, power efficiency, and software ecosystems will further accelerate this trend, creating a fertile ground for startups and enterprise adoption alike.

Access Complete Report: https://www.snsinsider.com/reports/exascale-computing-market-6035 

Conclusion Exascale computing is no longer a vision of the future—it is the powerhouse of today’s digital evolution. As industries align with the pace of computational innovation, those embracing exascale capabilities will lead the next wave of transformation. With its profound impact on science, security, and commerce, the exascale computing market is not just growing—it is redefining the very nature of progress. Businesses, researchers, and nations prepared to ride this wave will find themselves at the forefront of a smarter, faster, and more resilient future.

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Jagney Dave - Vice President of Client Engagement

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

[mordorintelligencemarketresearch]

Consumer Genomics Market: Redefining Personal Health Through DNA

The consumer genomics market is projected to grow at a compound annual growth rate (CAGR) of 20% over the forecast period. The consumer genomics market is transforming how individuals interact with their health, ancestry, and lifestyle choices. Once the domain of academic and clinical research, genomic testing is now widely accessible to the public through direct-to-consumer (DTC) platforms.

Market Growth and Key Drivers

Market research indicates that the global consumer genomics market is poised for significant growth in the coming years. The expansion is fueled by rising consumer interest in personalized health, falling costs of genomic sequencing, and increasing internet accessibility. In particular, demand for at-home DNA test kits has surged as individuals seek insights into their genetic risk factors, dietary compatibility, fitness profiles, and heritage.

As healthcare becomes more preventive and data-driven, consumer genomics offers a proactive approach to wellness—empowering individuals with actionable genetic information.

Health, Ancestry, and Lifestyle Applications

The market is broadly segmented into applications such as ancestry and genealogy, health risk assessment, pharmacogenomics, nutrigenomics, and reproductive health. While ancestry testing initially dominated the market, health-related applications are now gaining strong traction. Consumers are using genomic data to understand their susceptibility to conditions like cardiovascular disease, diabetes, or breast cancer, enabling early interventions or lifestyle adjustments.

Nutrigenomics and fitness genomics are also emerging niches, providing personalized recommendations for diet, exercise, and supplementation based on genetic profiles.

Technology and Accessibility

Technological advancements have played a key role in driving market growth. The development of next-generation sequencing (NGS), cloud-based data platforms, and AI-powered interpretation tools has enabled faster, more affordable, and more accurate genetic analysis. These technologies are not only improving the quality of genomic insights but also enhancing the consumer experience through user-friendly mobile apps and interactive reports.

Moreover, data integration with wearable health tech is allowing real-time correlation between genetic data and daily health metrics—bringing genomics into daily health management.

Privacy and Ethical Considerations

As genomic data becomes more widespread, concerns around privacy, data security, and ethical use are gaining attention. Consumers are becoming increasingly cautious about how their genetic information is stored, shared, or monetized. In response, companies are investing in stronger data protection measures, transparent privacy policies, and informed consent protocols to build trust and ensure regulatory compliance.

Ongoing discussions around data ownership and the ethical use of genomics in insurance or employment contexts will continue to shape industry practices and policy frameworks.

Regional Insights and Market Expansion

North America remains the largest market for consumer genomics, driven by high consumer awareness, favorable regulatory environments, and the presence of leading companies like 23andMe and AncestryDNA. Europe follows closely, with a growing interest in personalized healthcare and increasing government support for genomic research.

Asia-Pacific is emerging as a high-growth region, fueled by a large population base, rising healthcare expenditure, and an increasing shift toward preventive care. Countries like China, India, and Japan are investing in genomic infrastructure and expanding consumer access to DNA testing services.

Future Outlook

The consumer genomics industry is evolving beyond ancestry and entertainment, toward a more integrated role in preventive health and personalized medicine. With continued innovation, expanding global reach, and increasing demand for actionable genetic insights, the market is set for sustained expansion.

Looking ahead, strategic partnerships between genomics companies, healthcare providers, and tech platforms will drive the next wave of growth—bringing personalized, data-driven health solutions to the mainstream.

Conclusion 

The consumer genomics industry future looks promising, with innovations and trends likely to shape its landscape significantly. Companies that adapt to these changes and leverage new technologies will be best positioned to capitalize on the expanding market. For a more in-depth analysis and future predictions, consider exploring the full market report by Mordor Intelligence. 

For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence:

[market-insider]

AI In Oncology Market Trends and Analysis: Comprehensive Overview of Market Size, Share, Growth

The global AI in oncology market size is estimated to reach USD 19.17 billion by 2030, expanding at a CAGR of 26.17% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness significant growth owing to increasing prevalence of cancer among the global population, propelling the need to develop technologically advanced products to diagnose, treat, and analyze cancer. For instance, the International Agency for Research on Cancer (IARC) expects over 20.7 million new cases in 2023. Moreover, AI enables early detection, crucial for lowering mortality, especially through efficient screening programs.

Emerging markets are witnessing a rising prevalence of cancer due to various factors, including lifestyle changes & aging populations. The surge in cancer cases in these markets creates a demand for advanced technologies like AI in oncology to improve early detection, personalized treatment, and overall patient outcomes. For instance, in January 2024, India's first AI-Precision Oncology Centre (POC) was launched at Apollo Cancer Centre in Bengaluru. The POC will utilize the vast possibilities offered by AI to help oncologists, patients, and caregivers achieve the best possible results within a specified time frame.

AI is transforming the field of oncology by integrating vast datasets from multi-omics analyses with the latest developments in deep learning and high-performance computing techniques. AI applications are expanding to include new detection, screening, diagnosis, and classification approaches, cancer genomics characterization, tumor microenvironment analysis, prognostic and predictive biomarkers assessment, and strategies for follow-up and drug discovery. For instance, in October 2022, Model Medicines launched an oncology program focusing on identifying and developing therapeutics against two epigenetic and oncogenic targets, focusing on applications for solid and hematological malignancies.

The major players operating in the market are adopting strategies such as collaborations and partnerships with a major focus on development of newer products to aid in the early diagnosis of cancer, meet rising demand, and enhance research and development pipeline. For instance, in December 2022, AstraZeneca collaborated with Clinithink to launch an AI project for lung cancer. This project aims to detect lung cancer at an early stage to aid in the developing of effective treatment.

Furthermore, in November 2022, Google Health entered into a partnership with iCAD, Inc. for the improvement of breast cancer screening using the company’s artificial intelligence technology. Additionally, a number of public and private organizations are focusing on funding and investment for R&D in AI-based oncology screening products. For instance, in March 2023, Artera received funding of USD 90 million for the launch and distribution of the ArteraAI Prostate Test, the first developed test for predicting therapy in localized prostate cancer.

For More Details or Sample Copy please visit link @: AI In Oncology Market Report

AI In Oncology Market Report Highlights

Based on component type, the software solutions segment is anticipated to grow at the fastest CAGR over the forecast period, owing to increasing adoption of software solutions for a wide number of applications due to the better outcomes offered by this component

Based on cancer type, the prostate cancer segment is anticipated to grow at the fastest CAGR over the forecast period in the market with rising prevalence amongst the population. Prostate cancer generally affects 13 out of every 100 men in the U.S., according to the data published by CDC

Based on application type, the research and development segment is expected to grow at the lucrative CAGR over the forecast period. This is attributable to the widespread adoption and amalgamation of advanced AI-enabled algorithms in pharmaceutical companies

Based on end-use, the hospitals dominated the market and registered the fastest growth owing to growing number of companies collaborating or introducing AI-powered cancer care solutions in hospitals

North America dominated the market due to the availability of favorable government initiatives and digital infrastructure to provide digital solutions to patients

[versatile-blogger-1]

Genomics Market Expected To Witness High Growth Driven By Advancements In Technology And Rising Demand For Personalized Medicine

A) Market Overview:

Genomics is the study of genes and their functions, with a focus on understanding the structure, function, evolution, mapping, and editing of genomes. It plays a crucial role in personalized medicine, drug discovery, and the development of precision therapies. The market mainly consists of products such as instruments & consumables, services, and software used in genomic research and diagnostics.

The global Genomics Market is estimated to be valued at US$ 46.2 Bn in 2023 and is expected to exhibit a CAGR of 12.4% over the forecast period 2023-2028, as highlighted in a new report published by Coherent Market Insights.

B) Market Dynamics:

The global Genomics Market is driven by two major factors. Firstly, advancements in technology have revolutionized genomics research and diagnostics. The development of Next-Generation Sequencing (NGS) technologies and its applications in various genomic studies have significantly contributed to market growth. NGS enables faster and cost-effective sequencing of DNA, RNA, and proteins, thereby facilitating a deeper understanding of diseases at a molecular level.

Secondly, there is a rising demand for personalized medicine, which utilizes genomic information to tailor medical treatments to individual patients. The increasing prevalence of chronic diseases such as cancer and genetic disorders has created a need for more targeted therapies. Genomic testing enables the identification of specific genetic mutations associated with these diseases, allowing for personalized treatment plans.

C) Market Key Trends:

One key trend observed in the Genomics Market is the growing adoption of direct-to-consumer genetic testing. Companies such as 23andMe provide consumers with the opportunity to access their genetic information through at-home testing kits. This trend has gained popularity due to increased consumer awareness and curiosity about their DNA and ancestry.

For example, 23andMe offers ancestry reports, health predisposition reports, and carrier status reports, providing individuals with insights into their genetic background and potential health risks. This trend is expected to continue, as more people are interested in exploring their genetic information for various purposes.

D) SWOT Analysis:

Strength:

1. Advancements in technology - Continued advancements in genomic technologies such as NGS drive the market's growth.

2. Increasing demand for personalized medicine - The rising prevalence of chronic diseases and genetic disorders fuels the adoption of genomic approaches in clinical decision-making.

Weakness:

1. High costs associated with genomic testing - The cost of genomic tests and sequencing technologies may limit their accessibility, hindering market growth.

2. Regulatory challenges - Stringent regulations regarding the use and sharing of genetic data pose challenges for the market expansion.

Opportunity:

1. Growing applications in non-invasive prenatal testing - Genomics has the potential to revolutionize prenatal care by enabling non-invasive detection of fetal genetic abnormalities.

2. Expanding use of genomics in agriculture - The agricultural sector can benefit from genomics-based technologies for crop improvement and disease resistance.

Threats:

1. Ethical and privacy concerns - The collection and utilization of genetic data raise ethical questions and privacy concerns among individuals and regulatory bodies.

2. Lack of awareness and limited infrastructure - Limited awareness about genomics and inadequate infrastructure in certain regions can hinder market growth.

E) Key Takeaways:

- The global genomics market is expected to witness high growth, exhibiting a CAGR of 12.4% over the forecast period, driven by advancements in technology and rising demand for personalized medicine.

- North America is currently the largest market for genomics, owing to the presence of well-established healthcare infrastructure, increased funding for genomics research, and a growing consumer base for direct-to-consumer genetic testing.

- Key players operating in the global genomics market include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Illumina, Pacific Biosciences, Oxford Nanopore Technologies, 23andMe, Foundation Medicine, Hoffmann-La Roche Ltd., and Myriad Genetics Inc. These players focus on product development, partnerships, and acquisitions to maintain their market position and enhance their product offerings.

[datastring]

Automatic Pharmaceuticals Packaging Equipment Market set to hit $2294.5 million by 2035

Industry revenue for Automatic Pharmaceuticals Packaging Equipment is estimated to rise to $2294.5 million by 2035 from $889.2 million of 2024. The revenue growth of market players is expected to average at 9.0% annually for the period 2024 to 2035.

Detailed Analysis - https://datastringconsulting.com/industry-analysis/automatic-pharmaceuticals-packaging-equipment-market-research-report

Automatic Pharmaceuticals Packaging Equipment is critical across several key applications including pharmaceutical bottle filling, blister packaging, carton packaging and iv bags & plastic vials packaging. The report unwinds growth & revenue expansion opportunities at Automatic Pharmaceuticals Packaging Equipment’s Product Type, System Type, Application and End User including industry revenue forecast.

Industry Leadership and Competitive Landscape

The Automatic Pharmaceuticals Packaging Equipment market is characterized by intense competition, with a number of leading players such as Bosch Packaging Technology, Uhlmann Group, IMA S.p.A, Krber AG, Marchesini Group, MG2, MULTIVAC Group, OPTIMA Packaging Group GmbH, Romaco Pharmatechnik, Truking Technology Limited, Vanguard Pharmaceutical Machinery and WeighPack Systems Inc..

The Automatic Pharmaceuticals Packaging Equipment market is projected to expand substantially, driven by the growing demand for genomic medicine and adoption of ai in pharmaceutical packaging. This growth is expected to be further supported by Industry trends like Stringent Regulatory Compliances Globally.

Moreover, the key opportunities, such as expansion in emerging markets, technological innovations and focus on eco-friendly pharmaceutical packaging solutions, are anticipated to create revenue pockets in major demand hubs including U.S., Germany, China, Japan and India.

Regional Shifts and Evolving Supply Chains

North America and Europe are the two most active and leading regions in the market. With challenges like high cost of implementation and regulatory complications, Automatic Pharmaceuticals Packaging Equipment market’s supply chain from raw material procurement / design & development / production to end user is expected to evolve & expand further; and industry players will make strategic advancement in emerging markets including Brazil, Mexico and South Africa for revenue diversification and TAM expansion.

About DataString Consulting

DataString Consulting offers a complete range of market research and business intelligence solutions for both B2C and B2B markets all under one roof. We offer bespoke market research projects designed to meet the specific strategic objectives of the business. DataString’s leadership team has more than 30 years of combined experience in Market & business research and strategy advisory across the world. DataString Consulting’s data aggregators and Industry experts monitor high growth segments within more than 15 industries on an ongoing basis.

DataString Consulting is a professional market research company which aims at providing all the market & business research solutions under one roof. Get the right insights for your goals with our unique approach to market research and precisely tailored solutions. We offer services in strategy consulting, comprehensive opportunity assessment across various sectors, and solution-oriented approaches to solve business problems.

[industrynewsupdates]

Future of GPU As A Service Market: Trends and Forecast

The global GPU as a Service (GPUaaS) market is projected to reach USD 12.26 billion by 2030, growing at a CAGR of 22.9% from 2025 to 2030, according to a recent report by Grand View Research, Inc. This growth is being largely fueled by the increasing deployment of Artificial Intelligence (AI) and Machine Learning (ML) technologies across a wide range of industries. These technologies require extensive computational resources, a demand that Graphics Processing Units (GPUs) are well-equipped to meet. GPUaaS offers users the advantage of scalability, enabling them to adjust computing power in alignment with project-specific needs. As a result, demand for GPUaaS is rising in tandem with the broader adoption of AI and ML.

The rapid expansion of cloud computing has further accelerated the growth of GPUaaS. Leading cloud service providers are offering GPU-powered virtual machines to support tasks such as deep learning, data processing, graphics rendering, and scientific computing. These services democratize access to powerful computing capabilities, making high-performance GPUs available to users who may not be able to afford or manage on-premise hardware. For example, Amazon Web Services (AWS) delivers a range of GPU instances through its Amazon EC2 platform, designed to support varying computational requirements.

GPUaaS gives users—whether enterprises or individual developers—the flexibility to scale their GPU usage dynamically, adapting to different workload demands. This elasticity is especially attractive for organizations with fluctuating or project-based GPU needs. Google Cloud Platform (GCP) exemplifies this flexibility by offering high-performance GPU instances such as NVIDIA A100 Tensor Core GPUs, which are built on the NVIDIA Ampere architecture. These GPUs provide significant performance gains, particularly for AI, ML, and high-performance computing (HPC) workloads.

North America leads the market in terms of revenue generation. The region’s strong emphasis on digital transformation, particularly among enterprise sectors, makes GPUaaS a strategic asset in deploying AI and big data technologies. North America plays a critical role in the global cloud ecosystem, with increasing investments in infrastructure to support GPU-intensive operations.

On the other hand, the Asia Pacific region is anticipated to be the fastest-growing market over the forecast period. This growth is attributed to the region’s proactive adoption of emerging technologies, with countries like China, India, Japan, South Korea, Australia, and Singapore leading the way. Their investments in AI research, smart cities, and digital platforms continue to fuel the demand for scalable GPU resources.

Curious about the GPU As A Service Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends. 

GPU as a Service (GPUaaS) Market: Frequently Asked Questions

1. What is the expected size of the GPUaaS market by 2030?

The global GPUaaS market is projected to reach USD 12.26 billion by 2030, growing at a CAGR of 22.9% from 2025 to 2030.

2. What’s driving the demand for GPUaaS?

Rising adoption of AI and ML, increasing data volumes, demand for flexible cloud computing solutions, and growing use of GPU-accelerated applications across industries.

3. What are the benefits of GPUaaS?

• Scalability on demand

• Cost-efficiency

• Easy integration with AI and data analytics tools

• Faster time-to-market for compute-heavy applications

4. Which industries benefit most from GPUaaS?

Key sectors include:

• Healthcare (medical imaging, genomics)

• Finance (fraud detection, algorithmic trading)

• Automotive (autonomous vehicle training)

• Entertainment (3D rendering, VFX)

• Research & academia

5. Which region leads the GPUaaS market?

North America is the largest market, driven by strong cloud infrastructure, tech adoption, and enterprise digital transformation efforts

6. Which region is expected to grow the fastest?

Asia Pacific is anticipated to grow rapidly due to aggressive investment in emerging tech by countries like China, India, Japan, and South Korea.

Order a free sample PDF of the GPU As A Service Market Intelligence Study, published by Grand View Research.

[jamesmilleer2407]

Breaking Down the Sectors Leading the top 10 nasdaq stocks

The Nasdaq Composite is home to some of the world’s most transformative companies—those that define sectors, influence technology adoption, and shape enterprise behavior across the globe. While the index includes thousands of publicly listed firms, the top 10 nasdaq stocks stand out for their leadership, operational scale, and foundational role in the digital economy.

These entities span a range of domains, from artificial intelligence and cloud computing to e-commerce, semiconductors, and biotechnology. Their influence extends beyond markets, deeply embedded in consumer lives, infrastructure, and cross-border commerce.

Technology Giants Driving Structural Shifts

Technology dominates the upper tier of Nasdaq. The top 10 nasdaq stocks feature companies that deliver infrastructure for cloud operations, productivity software, and data-driven services. These platforms enable enterprises to operate flexibly, scale on demand, and analyze vast datasets for strategic decision-making.

The focus areas include edge computing, AI model deployment, collaborative ecosystems, and real-time communication. Such platforms power workflows across industries—logistics, healthcare, education, and manufacturing alike.

Semiconductor Ecosystems and High-Performance Processing

Semiconductors are the engine behind almost every modern device. The top 10 nasdaq stocks include major chip manufacturers specializing in logic processors, GPUs, and memory technologies. These chips support a range of devices from smartphones to autonomous vehicles, and critical infrastructure such as AI training servers and IoT applications.

Their role is especially important in enabling advancements in robotics, quantum computing, and 5G integration. As demand for efficiency, speed, and computing scale increases, these hardware companies continue to evolve with new manufacturing processes and power-saving architectures.

Biotech Leaders Transforming Health Sciences

Several biotechnology and pharmaceutical companies are among the top 10 nasdaq stocks, recognized for their innovation in genomics, molecular diagnostics, and personalized therapy development. These firms focus on treatments that tackle complex diseases and contribute to advancements in healthcare delivery.

Their research efforts are driven by AI-assisted modeling, automated lab testing, and cloud-based trial management systems. By merging biology and data, these organizations are playing a key role in the evolution of modern medicine.

E-Commerce and Global Consumer Platforms

Digital retail has become an integral part of global commerce, with firms in the top 10 nasdaq stocks leading in logistics integration, virtual storefront management, and behavioral analytics. These platforms facilitate real-time inventory tracking, user-based customization, and high-speed fulfillment systems.

Their operations support vast product ecosystems and provide infrastructure that connects manufacturers, sellers, and buyers across multiple regions.

Fintech and Scalable Payment Systems

Several companies within the top 10 nasdaq stocks operate at the intersection of finance and technology, offering mobile payments, e-commerce checkout tools, and financial infrastructure APIs. These firms enable seamless global transactions and scalable platforms for businesses of all sizes.

Through security enhancements, intuitive interfaces, and backend automation, fintech platforms are streamlining user experience while expanding access to digital commerce solutions.

Cybersecurity and Data Resilience

With increased digital activity comes a greater need for cybersecurity. The top 10 nasdaq stocks include organizations that offer identity protection, intrusion prevention systems, and compliance monitoring tools. These services are critical for securing enterprise networks, hybrid cloud deployments, and endpoint devices.

Cyber platforms today are built to address adaptive threats using machine learning, behavioral analysis, and decentralized access control. Their services support the operational continuity of corporations, institutions, and governments alike.

Clean Energy and Electrification Technology

Environmental innovation is making its mark on the Nasdaq, with some of the top 10 nasdaq stocks focused on clean energy production, storage solutions, and smart grid capabilities. These firms are helping reshape energy use across industrial and residential landscapes through solar hardware, EV battery advancements, and real-time energy analytics.

Their platforms align with long-term global objectives centered around emission reduction, energy efficiency, and infrastructure modernization.

Artificial Intelligence and Data Platforms

AI continues to gain traction across sectors, and firms within the top 10 nasdaq stocks develop tools that analyze patterns, automate processes, and support predictive operations. These platforms are used in retail, healthcare, logistics, and more—delivering insights that optimize everything from inventory flow to patient outcomes.

The integration of natural language processing, image recognition, and machine learning modules further enhances decision-making across enterprise layers.

Streaming Services and Content Ecosystems

Digital entertainment continues to evolve through streaming platforms that offer global access to video, music, and interactive content. Several firms in the top 10 nasdaq stocks lead in content delivery, subscription systems, and personalized user interfaces.

These platforms use advanced algorithms to recommend content, monitor engagement, and optimize experience across smart devices and mobile ecosystems.

Automation and Smart Logistics Infrastructure

The rise of automation is visible in companies that focus on industrial logistics, robotics, and smart supply chains. The top 10 nasdaq stocks in this category build systems that enhance speed, reduce errors, and enable autonomous decision-making in physical operations.

Their tools are used in warehousing, shipping, manufacturing, and urban mobility—shaping the future of efficiency in physical commerce.

[prachicmi2]

Healthcare Predictive Analytics Market to Soar Owing to AI Integration

Healthcare predictive analytics involves the use of advanced data mining, machine learning algorithms, and statistical tools to predict patient outcomes, disease progression, and operational bottlenecks. By aggregating data from electronic health records (EHRs), medical imaging, genomics, and wearable devices, predictive analytics solutions empower providers to identify at-risk populations, optimize treatment protocols, reduce readmission rates, and allocate resources more effectively.

Healthcare Predictive Analytics Market Insights include improved clinical decision support, personalized care plans, proactive risk management, and cost containment. Hospitals and clinics leverage predictive models to forecast patient admissions, supply chain demands, and staffing needs, while payers use these insights for population health management and fraud detection.

Get more insights on, Healthcare Predictive Analytics Market

[aimarketresearch]

Middle East and Africa Quantum Computing Market Size, Share, Trends, Key Drivers, Growth Opportunities and Competitive Outlook

Middle East and Africa Quantum Computing Market  - Size, Share, Demand, Industry Trends and Opportunities

Middle East and Africa Quantum Computing Market, By System (Single Qubit Quantum System, Multiple Qubit System), Qubits (Trapped Ion Qubits, Semiconductor Qubits and Super Conducting), Offering (Systems, Services), Deployment Model (On-Premises, Cloud), Component (Hardware, Software and Services), Application (Cryptography, Simulation, Parallelism, Machine Learning, Algorithms, Others), Logic Gates (Toffoli Gate, Hadamard Gate, Pauli Logic Gates and Others), Verticals (Banking And Finance, Healthcare and Pharmaceuticals, Defense, Automotive, Chemical, Utilities, Others), Country (South Africa, U.A.E, Israel, Egypt, Saudi Arabia and Rest of Middle East and Africa) Industry Trends.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @

**Segments**

The Middle East and Africa quantum computing market is expected to witness significant growth over the forecast period. The market can be segmented based on components, applications, and end-users. In terms of components, the market can be divided into hardware, software, and services. Hardware components include quantum processors, quantum memory, and quantum gates, among others. Software components encompass quantum algorithms and quantum software development kits (SDKs). Services segment consists of consulting, training, and maintenance services related to quantum computing technologies.

Moving on to applications, the Middle East and Africa quantum computing market can be categorized into cybersecurity, optimization, machine learning, simulation, and others. Quantum computing is increasingly being utilized in cybersecurity to enhance encryption techniques and secure sensitive data. Optimization applications include supply chain management, logistics, and financial portfolio optimization. Machine learning is another key application area where quantum computing can significantly improve complex algorithms and predictive modeling. Furthermore, simulation applications involve quantum simulations for material design, drug discovery, and weather forecasting, among others.

When considering end-users, the market can be segmented into healthcare, BFSI (Banking, Financial Services, and Insurance), aerospace and defense, energy and utilities, and others. The healthcare sector is exploring quantum computing for personalized medicine, genomics, and drug discovery applications. The BFSI industry is leveraging quantum computing for risk management, fraud detection, and algorithmic trading. Aerospace and defense companies are utilizing quantum computing for advanced simulations, cryptography, and satellite communications. Energy and utilities sector are adopting quantum computing for grid optimization, renewable energy integration, and predictive maintenance.

**Market Players**

- IBM Corporation - D-Wave Systems Inc. - Rigetti & Co, Inc. - Google LLC - Microsoft Corporation - Intel Corporation - Anyon Systems Inc. - QC Ware Corp - IonQ Inc.

The Middle East and Africa quantum computing market is witnessing increased investments in research and development activities, strategic partnerships, and collaborations among key market players. IBM Corporation, a prominent player in the quantum computing space, has been focusing on advancing quantum hardware and software capabilities. D-Wave Systems Inc., known for its quantum annealing technology, has been expanding its presence in the region through partnerships with local organizations. Rigetti & Co, Inc. has been making significant advancements in superconducting quantum processors, attracting attention from various industries. Google LLC and Microsoft Corporation are also actively involved in quantum computing research and development, driving innovation in the market.

Market players such as Intel Corporation, Anyon Systems Inc., QC Ware Corp, and IonQ Inc. are contributing to the growth of the Middle East and Africa quantum computing market through their technological expertise and product offerings. These companies are focusing on addressing the specific requirements of industries such as healthcare, BFSI, aerospace and defense, and energy and utilities. With the increasing demand for quantum computing solutions in the region, market players are expected to continue investing in expanding their product portfolios and enhancing their capabilities to cater to diverse end-user needs.

Overall, the Middle East and Africa quantum computing market presents significant growth opportunities driven by the increasing adoption of quantum technologies across various industries. The market players are playing a crucial role in driving innovation, developing advanced solutions, and expanding their market presence through strategic initiatives. As the market continues to evolve, collaborations, partnerships, and investments in research and development will be key factors influencing the competitive landscape and growth trajectory of the quantum computing market in the region.

Access Full 350 Pages PDF Report @

Key points covered in the report: -

The pivotal aspect considered in the Middle East and Africa Quantum Computing Market report consists of the major competitors functioning in the market.

The report includes profiles of companies with prominent positions in the market.

The sales, corporate strategies and technical capabilities of key manufacturers are also mentioned in the report.

The driving factors for the growth of the Middle East and Africa Quantum Computing Market are thoroughly explained along with in-depth descriptions of the industry end users.

The report also elucidates important application segments of the market to readers/users.

This report performs a SWOT analysis of the market. In the final section, the report recalls the sentiments and perspectives of industry-prepared and trained experts.

The experts also evaluate the export/import policies that might propel the growth of the Middle East and Africa Quantum Computing Market.

The Middle East and Africa Quantum Computing Market report provides valuable information for policymakers, investors, stakeholders, service providers, producers, suppliers, and organizations operating in the industry and looking to purchase this research document.

Reasons to Buy:

Review the scope of the Middle East and Africa Quantum Computing Market with recent trends and SWOT analysis.

Outline of market dynamics coupled with market growth effects in coming years.

Middle East and Africa Quantum Computing Market segmentation analysis includes qualitative and quantitative research, including the impact of economic and non-economic aspects.

Middle East and Africa Quantum Computing Market and supply forces that are affecting the growth of the market.

Market value data (millions of US dollars) and volume (millions of units) for each segment and sub-segment.

and strategies adopted by the players in the last five years.

Browse Trending Reports:

South America Biostimulants Market North America Non Ionic Surfactants Market Asia Pacific Sweet Potato Powder Market North America Sweet Potato Powder Market Europe Sweet Potato Powder Market Middle East And Africa Sweet Potato Powder Market India Non Stick Cookware Market Europe Reverse Logistics Market Asia Pacific Reverse Logistics Market North America Reverse Logistics Market Middle East And Africa Reverse Logistics Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com

[industrystudyreport]

DNA Sequencing Market: Who Are the Key Innovators?

DNA Sequencing Industry Overview

The global DNA Sequencing Market, valued at an estimated USD 12.39 billion in 2023, is projected to expand at a compound annual growth rate (CAGR) of 21.65% from 2024 to 2030. This growth is facilitated by the rapid progress in technology and bioinformatics, which has enabled the detection of DNA variations and the subsequent identification of variants associated with an elevated risk of disease.

Furthermore, the increasing utilization of Next-Generation and Whole-Genome Sequencing technologies within clinical diagnosis applications is broadening the scope of DNA sequencing. These advancements are expected to contribute to market growth over the forecast period.

Detailed Segmentation:

Product & Service Insights

The services segment is anticipated to witness the fastest CAGR over the forecast period. Comprehensive data analysis, library preparation, identification & quantification of the binding sites of proteins of DNA, DNA methylation profiles on a genome-wide scale, shotgun sequencing, primer walking sequencing, bacterial artificial chromosome end sequencing, and expressed sequence tags are among the few sequencing services available in the market. The demand for the services segment is expected to be driven by the availability of several players offering these services. GENEWIZ, Illumina, QIAGEN, Eurofins Genomics LLC, GenScript, Applied Biological Materials Inc., and Agilent Technologies are a few major service providers operating in the market.

Technology Insights

Based on technology, the next generation sequencing segment led the market with a largest revenue share of 87.29% in 2023. The radical advances in these technologies and the reducing time and declining cost of sequencing have made genome sequencing affordable and more accurate. In addition, NGS technology is gaining popularity as a routine clinical diagnostic test, particularly with the COVID-19 pandemic, which positively impacts the segment’s revenue share.

Workflow Insights

Based on workflow, the sequencing segment held the market with a largest revenue share of 56.96% in 2023. This step enables the sequence profiling of the genome and DNA-protein interactions. It is an integral part of the entire DNA sequencing workflow in research and discovery studies, which accounts for its larger share. The ability of sequencers to generate a large amount of data in a relatively short period accelerates understanding of human health and disease treatments. Moreover, major players like Illumina, Inc and Thermo Fisher Scientific, Inc. provide novel platforms for sequencing workflow.

Application Insights

In terms of application, the oncology segment led the market with a largest revenue share of 25.53% in 2023. Technology holds great potential in clinical research and development of cancer diagnostics and therapeutics. The value of these technologies in companion diagnostics and precision medicine is widely recognized by clinicians and companies, which is anticipated to propel the segment over the forecast period. NGS is widely used in oncology, where gene mutations are sequenced and cataloged to develop new cancer diagnoses & treatment methods.

End-use Insights

The clinical research segment is projected to witness the fastest CAGR over the forecast period. NGS technologies have gained immense popularity because of their massive parallel sequence analysis capability that allows simultaneous screening of multiple genes. This potential of NGS technologies makes it a preferred choice for clinical testing procedures, even in the testing of multiple gene markers with a smaller number of nucleic acids. Moreover, the implementation of DNA analysis for studying tumor heterogeneity, the discovery of new cancer-related genes, and the identification of alterations related to tumorigenesis are expected to result in significant growth of this segment.

Regional Insights

The Europe market is expected to grow at a significant CAGR during the forecast period, due to the increasing R&D investments and continuous research by scientists which has boosted the demand for innovative NGS solutions. For instance, in March 2020, using Thermo Fisher Scientific’s NGS research assay, a team of Italian researchers analyzed the SARS-CoV-2 genome from specimens collected locally and suggested that the rapidly spreading virus's genome is stable.

Gather more insights about the market drivers, restraints, and growth of the DNA Sequencing Market

Key Companies & Market Share Insights

The following are the leading companies in the DNA sequencing market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these DNA sequencing companies are analyzed to map the supply network.

Thermo Fisher Scientific, Inc

Agilent Technology

Illumina, Inc.

QIAGEN

F. Hoffmann-La Roche Ltd.

Macrogen, Inc.

PerkinElmer Genomics

PacBio

BGI

Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.

Recent Developments

In November 2023, Illumina, Inc. launched its Global Health Access Initiative to support access to public health sequencing tools in low- and middle-income countries

In August 2023, PacBio entered into an agreement to acquire Apton Biosystems. This acquisition is anticipated to accelerate the development of Short-read Sequencer, propelling the market growth

In August 2023, PacBio announced a research collaboration with the University of Washington to analyze the ability of HiFi long-read WGS. This is anticipated to increase the analytical rates in individuals with various genetic conditions